Global flavor and fragrance manufacturer applying synthetic biology and encapsulation science to develop next-generation natural food ingredients.
Symrise AG is one of the world's largest producers of flavors, fragrances, and cosmetic ingredients, supplying the food, beverage, personal care, and household goods industries globally. In EU-funded research, they participate as an industrial application partner, bringing proprietary knowledge of flavor chemistry, ingredient formulation, and commercial production requirements to academic consortia. Their H2020 involvement spans two complementary R&D fronts: biosynthetic production of flavonoid flavor compounds using engineered microorganisms, and advanced encapsulation systems for delivering bioactive food ingredients with improved stability and bioavailability. Their role in these projects is to validate research outputs against real-world industrial specifications and provide a pathway to commercial scale-up.
SynBio4Flav (2019–2023) focused specifically on producing functionalized flavonoids via synthetic microbial consortia, directly aligned with Symrise's core business of natural flavor ingredient supply.
ENCAP4HEALTH (2020–2024) addressed encapsulation of plant proteins and bioactives using biopolymers, a key formulation challenge for functional food ingredients.
SynBio4Flav involved microbial chassis engineering (P. putida, E. coli, S. albus, S. cerevisiae) for distributed catalysis of flavor-relevant molecules.
ENCAP4HEALTH explored smart processing, digestion behavior, and plant protein systems, reflecting growing interest in health-directed ingredient development beyond traditional flavoring.
Symrise's H2020 entry point (SynBio4Flav, 2019) was firmly upstream: engineering microorganisms to biosynthesize flavonoid molecules, an approach that could replace expensive or unsustainable natural extraction. By 2020, with ENCAP4HEALTH, their focus shifted downstream toward what happens to ingredients after they are made — how bioactives survive processing, how they behave during digestion, and how biopolymer encapsulation can protect and deliver them effectively. This is a logical industrial progression: first secure a sustainable production route for valuable compounds, then solve the formulation and delivery challenges that determine whether those compounds work in real food products.
Symrise appears to be building a vertically integrated innovation capability — from fermentation-based biosynthesis of natural flavor compounds through to encapsulation systems that ensure those compounds are stable, bioavailable, and effective in finished food products.
Symrise participates exclusively as a consortium partner, never as project coordinator — consistent with a large industrial company that joins research consortia to contribute application-side expertise and absorb scientific advances rather than to lead academic work. Their EC funding per project is modest relative to consortium budgets, suggesting they take a focused, expert-contributor role rather than a work-package-leading one. With 21 unique partners across just 2 projects, they are plugged into large, internationally diverse consortia where they are likely the sole or primary industrial flavor/fragrance company at the table.
Despite only two projects, Symrise has accumulated 21 unique consortium partners spanning 13 countries — indicating they joined large, multi-partner RIA consortia with broad European and likely global academic participation. This breadth of connections across a very small number of projects suggests targeted entry into high-visibility collaborative research networks.
Symrise is one of the top four global flavor and fragrance companies (alongside Givaudan, IFF, and Firmenich), which means any research output they validate or co-develop has a credible and fast route to industrial-scale commercial application. For a consortium working on biosynthetic flavor compounds or functional food encapsulation, having Symrise as a partner provides both market validation and a potential commercialization pathway that purely academic or SME partners cannot offer. Their participation signals that a project's outputs are commercially serious, not just scientifically interesting.
